<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Diabetes Views</title>
	<atom:link href="http://diabetesviews.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://diabetesviews.com</link>
	<description>Facts, reviews and opinions on everything related to diabetes</description>
	<lastBuildDate>Sun, 13 Nov 2016 21:23:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.7</generator>
	<item>
		<title>Senseonics Eversense, an implantable CGM</title>
		<link>http://diabetesviews.com/2016/11/senseonics-eversense-an-implantable-cgm/</link>
		<comments>http://diabetesviews.com/2016/11/senseonics-eversense-an-implantable-cgm/#respond</comments>
		<pubDate>Sun, 13 Nov 2016 18:31:46 +0000</pubDate>
		<dc:creator><![CDATA[views]]></dc:creator>
				<category><![CDATA[Continuous Glucose Monitoring (CGM)]]></category>
		<category><![CDATA[Senseonics]]></category>

		<guid isPermaLink="false">http://diabetesviews.com/?p=40</guid>
		<description><![CDATA[Senseonics Eversense is a continuous glucose monitoring system (CGM) with a sensor which is implanted under the skin. It measures glucose in the interstitial fluid for up to six months. The system consists of the implantable sensor, an external transmitter, and a smartphone app. The sensor continuously measures glucose levels and sends the results to<a class="sup-readmore" href="http://diabetesviews.com/2016/11/senseonics-eversense-an-implantable-cgm/">Read More</a>]]></description>
		<wfw:commentRss>http://diabetesviews.com/2016/11/senseonics-eversense-an-implantable-cgm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Difference between Freestyle Libre and Libre Pro</title>
		<link>http://diabetesviews.com/2016/11/difference-between-freestyle-libre-and-libre-pro/</link>
		<comments>http://diabetesviews.com/2016/11/difference-between-freestyle-libre-and-libre-pro/#respond</comments>
		<pubDate>Thu, 03 Nov 2016 13:14:54 +0000</pubDate>
		<dc:creator><![CDATA[views]]></dc:creator>
				<category><![CDATA[Freestyle Libre]]></category>

		<guid isPermaLink="false">http://diabetesviews.com/?p=25</guid>
		<description><![CDATA[In September 2016, US FDA has approved Abbott&#8217;s Freestyle Libre Pro, a version of Freestyle Libre for medical professionals. This is a novel &#8220;flash&#8221; glucose monitoring system which measures glucose every 15 minutes and does not require any manual calibration. The patients wearing the Pro sensor cannot see any data collected by this device. Only<a class="sup-readmore" href="http://diabetesviews.com/2016/11/difference-between-freestyle-libre-and-libre-pro/">Read More</a>]]></description>
		<wfw:commentRss>http://diabetesviews.com/2016/11/difference-between-freestyle-libre-and-libre-pro/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Afrezza, an ultra-rapid-acting inhaled insulin. Will it be a success?</title>
		<link>http://diabetesviews.com/2016/11/afrezza-an-ultra-rapid-acting-inhaled-insulin-will-it-be-a-success/</link>
		<comments>http://diabetesviews.com/2016/11/afrezza-an-ultra-rapid-acting-inhaled-insulin-will-it-be-a-success/#respond</comments>
		<pubDate>Wed, 02 Nov 2016 21:47:13 +0000</pubDate>
		<dc:creator><![CDATA[views]]></dc:creator>
				<category><![CDATA[Insulins]]></category>

		<guid isPermaLink="false">http://www.diabetesviews.com/?p=5</guid>
		<description><![CDATA[Afrezza is an ultra-rapid-acting insulin: it is faster than Humalog and Novorapid. Afrezza is not injected but inhaled – you don’t need the needles. A cartridge with 4 units of Afrezza is equivalent to 3.1 units of Humalog. What else do we know about Afrezza? Barriers to Afrezza’s success Break-Up With Sanofi Afrezza was previously<a class="sup-readmore" href="http://diabetesviews.com/2016/11/afrezza-an-ultra-rapid-acting-inhaled-insulin-will-it-be-a-success/">Read More</a>]]></description>
		<wfw:commentRss>http://diabetesviews.com/2016/11/afrezza-an-ultra-rapid-acting-inhaled-insulin-will-it-be-a-success/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Freestyle Libre as a CGM with alarms: a do-it-yourself solution</title>
		<link>http://diabetesviews.com/2016/04/freestyle-libre-as-a-cgm-with-alarms-a-do-it-yourself-solution/</link>
		<comments>http://diabetesviews.com/2016/04/freestyle-libre-as-a-cgm-with-alarms-a-do-it-yourself-solution/#respond</comments>
		<pubDate>Mon, 18 Apr 2016 12:14:44 +0000</pubDate>
		<dc:creator><![CDATA[views]]></dc:creator>
				<category><![CDATA[Continuous Glucose Monitoring (CGM)]]></category>
		<category><![CDATA[Do-it-yourself]]></category>
		<category><![CDATA[Freestyle Libre]]></category>

		<guid isPermaLink="false">http://diabetesviews.com/?p=17</guid>
		<description><![CDATA[A new do-it-yourself solution makes Abbott’s Freestyle Libre work as a continuous glucose monitor (CGM), with alarms if glucose goes too high or too low. Out of the box, Freestyle Libre is not made for continuous glucose monitoring. Libre is marketed as “flash glucose monitoring” which helps to overcome “alarm fatigue”, one of the complaints<a class="sup-readmore" href="http://diabetesviews.com/2016/04/freestyle-libre-as-a-cgm-with-alarms-a-do-it-yourself-solution/">Read More</a>]]></description>
		<wfw:commentRss>http://diabetesviews.com/2016/04/freestyle-libre-as-a-cgm-with-alarms-a-do-it-yourself-solution/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
